Michael A. Martino - Jan 1, 2022 Form 4 Insider Report for Ampio Pharmaceuticals, Inc. (AMPE)

Role
INTERIM CHAIRMAN AND CEO, Director
Signature
/s/ Daniel Stokely, Attorney-in-Fact
Stock symbol
AMPE
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
4
Date filed
1/3/2022, 07:15 PM
Previous filing
Nov 24, 2021
Next filing
May 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPE Stock Option (Right to Buy) Award $0 +250K $0.00 250K Jan 1, 2022 Common Stock 250K $0.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest on November 22, 2022.